The impact of cytokine gene polymorphisms on Epstein-Barr virus infection outcome in pediatric liver transplant recipients

Journal of Clinical Virology

Volumn 55, Issue 3, 2012, Pages 226-232

  Kasztelewicz, Beata ^a   Jankowska, Irena ^a   Pawłowska, Joanna ^a   Teisseyre, Joanna ^a   Dzierzanowska Fangrat, Katarzyna ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

CC chemokine ligand 2; Chronically high viral load; Cytokine gene polymorphism; EBV; IL12p40; Pediatric liver transplantation

Indexed keywords

ACICLOVIR; CHEMOKINE RECEPTOR CCR5; GAMMA INTERFERON; GANCICLOVIR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR ALPHA; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; VALGANCICLOVIR; VIRUS DNA;

3' UNTRANSLATED REGION; ARTICLE; CHILD; EPSTEIN BARR VIRUS INFECTION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; VARIABLE NUMBER OF TANDEM REPEAT; VIRUS LOAD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYTOKINES; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; LIVER TRANSPLANTATION; MALE; POLYMORPHISM, GENETIC; TRANSPLANTATION; TREATMENT OUTCOME;

EID: 84866381192     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2012.07.005     Document Type: Article

References (36)

1. Kamdar K.Y., Rooney C.M., Heslop H.E. Posttransplant lymphoproliferative disease following liver transplantation. Curr Opin Organ Transplant 2011, 16:274-280.
2. Vegso G., Hajdu M., Sebestyen A. Lymphoproliferative disorders after solid organ transplantation-classification, incidence, risk factors early detection and treatment options. Pathol Oncol Res 2011, 17:443-454.
3. Green M., Soltys K., Rowe D.T., Webber S.A., Mazareigos G. Chronic high Epstein-Barr viral load carriage in pediatric liver transplant recipients. Pediatr Transplant 2009, 13:319-323.
4. Gotoh K., Ito Y., Ohta R., Iwata S., Nishiyama Y., Nakamura T., et al. Immunologic and virologic analyses in pediatric liver transplant recipients with chronic high Epstein-Barr Virus loads. J Infect Dis 2010, 202:461-469.
5. Bidwell J., Keen L., Gallagher G., Kimberly R., Huizinga T., McDermott M.F., et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1999, 1:3-19.
6. Keen L.J. The extent and analysis of cytokine and cytokine receptor gene polymorphism. Transpl Immunol 2002, 10:143-146.
7. Bogunia-Kubik K., Mlynarczewska A.S., Jaskula E., Lange A. The presence of IFNG 3/3 genotype in the recipient associates with increased risk for Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation. Br J Haematol 2006, 132:326-332.
8. Bogunia-Kubik K., Jaskula E., Lange A. The presence of functional CCR5 and EBV reactivation after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 2007, 40:145-150.
9. Babel N., Vergopoulos A., Trappe R.U., Oertel S., Hammer M.H., Karaivnanov S., et al. Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients. Transplantation 2007, 84:387-391.
10. Lee T.C., Savoldo B., Barshes N.R., Rooney C.M., Heslop H.E., Gee A.P., et al. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients. Clin Transplant 2006, 20:389-393.
11. McAulay K.A., Haque T., Crawford D.H. Tumour necrosis factor gene polymorphism: a predictive factor for the development of post-transplant lymphoproliferative disease. Br J Cancer 2009, 101:1019-1027.
12. Thomas R.V., McAulay K., Higgins C., Wilkie G., Crawford D.H. Interferon gamma (IFN-gamma) polymorphism in posttransplantation lymphoproliferative disease. Blood 2005, 106:1502-1503.
13. Hoffmann T.W., Halimi J.-M., Buchler M., Velge-Roussel F., Goudeau A., Al Najjar A., et al. Association between a polymorphism in the IL-12p40 gene and cytomegalovirus reactivation after kidney transplantation. Transplantation 2008, 85:1406-1411.
14. Helminen M., Lahdenpohja N., Hurme M. Polymorphism of the interleukin-10 gene is associated with susceptibility to Epstein-Barr virus infection. J Infect Dis 1999, 180:496-499.
15. Hurme M., Helminen M. Polymorphism of the IL-1 gene complex in Epstein-Barr virus seronegative and seropositive adult blood donors. Scand J Immunol 1998, 48:219-222.
16. Stojanova J., Caillard S., Rousseau A., Marquet P. Post-transplant lymphoproliferative disease (PTLD): pharmacological, virological and other determinants. Pharmacol Res 2011, 63:1-7.
17. Witkin S.S., Gerber S., Ledger W.J. Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis 2001, 34:204-209.
18. Loeffler J., Michael S., Arlt E.M., Toliat M.R., Mezger M., Suk A., et al. Polymorphisms in the genes encoding chemokine receptor 5, interleukin-10, and monocyte chemoattractant protein 1 contribute to cytomegalovirus reactivation and disease after allogeneic stem cell transplantation. J Clin Microbiol 2006, 44:1847-1850.
19. Kasztelewicz B., Jankowska I., Pawlowska J., Teisseyre J., Grenda R., Pronicki M., et al. Epstein-Barr virus DNA load in peripheral blood mononuclear cells and whole blood from pediatric transplant recipients. Transpl Infect Dis 2011, 13:471-479.
20. Chung B.-S., Lee J.-K., Choi M.-H., Park M.H., Choi D., Hong S.-T. Single nucleotide polymorphisms of cytokine genes are associated with fibrosis of the intrahepatic bile duct wall in human clonorchiasis. Korean J Parasitol 2009, 47:145-151.
21. Hurme M., Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are coordinately regulated by both IL-1Ra and IL-1 beta genes. Eur J Immunol 1998, 28:2598-2602.
22. Bioque G., Crusius J.B.A., Koutroubakis I., Bouma G., Kostense P.J., Meuwissen S.G.M., et al. Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol 1995, 102:379-383.
23. Szalai C., Duba J., Prohaszka Z., Kalina A., Szabo T., Nagy B., et al. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD) Coincidence of elevated Lp(a) and MCP-1-2518 G/G genotype in CAD patients. Atherosclerosis 2001, 158:233-239.
24. Tarlow J.K., Blakemore A.I.F., Lennard A., Solari R., Hughes H.N., Steinkasserer A., et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993, 91:403-404.
25. Abdi R., Huong T.T.B., Sahagun-Ruiz A., Murphy P.M., Brenner B.M., Milford E.L., et al. Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation. J Am Soc Nephrol 2002, 13:754-758.
26. Santtila S., Savinainen K., Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1 beta production in vitro. Scand J Immunol 1998, 47:195-198.
27. Rodrigo E., Sanchez-Velasco P., Ruiz J.C., Fernandez-Fresnedo G., Lopez-Hoyos M., Pinera C., et al. Cytokine polymorphisms and risk of infection after kidney transplantation. Transplant Proc 2007, 39:2219-2221.
28. Nicholas J. Human gammaherpesvirus cytokines and chemokine receptors. J Interferon Cytokine Res 2005, 25:373-383.
29. Middeldorp J.M., Pegtel D.M. Multiple roles of LMP1 in Epstein-Barr virus induced immune escape. Semin Cancer Biol 2008, 18:388-396.
30. Nakayama T., Hieshima K., Nagakubo D., Sato E., Nakayama M., Kawa K., et al. Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus. J Virol 2004, 78:1665-1674.
31. Takegawa S., Jin Z., Nakayama T., Oyama T., Hieshima K., Nagakubo D., et al. Expression of CCL17 and CCL22 by latent membrane protein 1-positive tumor cells in age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorder. Cancer Sci 2008, 99:296-302.
32. Rovin B.H., Lu L., Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 1999, 259:344-348.
33. Holscher C. The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases. Med Microbiol Immunol 2004, 193:1-17.
34. Collison L.W., Vignali D.A.A. Interleukin-35: odd one out or part of the family?. Immunol Rev 2008, 226:248-262.
35. Stanilova S., Miteva L. Taq-I polymorphism in 3 UTR of the IL-12B and association with IL-12p40 production from human PBMC. Genes Immun 2005, 6:364-366.
36. Collison L.W., Workman C.J., Kuo T.T., Boyd K., Wang Y., Vignali K.M., et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007, 450:566-569.